Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Neurodevelopmental Disorders 1Fragile X Syndrome 1DiGeorge Syndrome 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 122q11 Deletion Syndrome 1

Interventions

Music Therapy 15Cognitive Behavioral Therapy 13Therapeutics 12Surveys and Questionnaires 12Psychiatric Rehabilitation 9Methods 9Standard of Care 8Psilocybin 7Educational Status 7Mindfulness 6Hypnosis 6Early Intervention, Educational 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Control Groups 5Art Therapy 5Aromatherapy 5Saline Solution 4Ketamine 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Behavior Therapy 4Autogenic Training 4Acupuncture Therapy 4Yoga 3Weights and Measures 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anxiety Disorders × Selective Serotonin Reuptake Inhibitors × Clear all
NCT06081348 2025-07-16

CALM

Holland Bloorview Kids Rehabilitation Hospital

Phase 2 Recruiting
130 enrolled

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡